334 related articles for article (PubMed ID: 29522272)
1. Presence of lytic Epstein-Barr virus infection in nasopharyngeal carcinoma.
Yu F; Lu Y; Petersson F; Wang DY; Loh KS
Head Neck; 2018 Jul; 40(7):1515-1523. PubMed ID: 29522272
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma.
Ke K; Wang H; Fu S; Zhang Z; Duan L; Liu D; Ye J
Chin Med J (Engl); 2014; 127(2):294-9. PubMed ID: 24438619
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV)-encoded RNA: automated in-situ hybridization (ISH) compared with manual ISH and immunohistochemistry for detection of EBV in pediatric lymphoproliferative disorders.
Fanaian NK; Cohen C; Waldrop S; Wang J; Shehata BM
Pediatr Dev Pathol; 2009; 12(3):195-9. PubMed ID: 18442302
[TBL] [Abstract][Full Text] [Related]
4. Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals.
Tao Q; Srivastava G; Chan AC; Chung LP; Loke SL; Ho FC
J Med Virol; 1995 Jan; 45(1):71-7. PubMed ID: 7714494
[TBL] [Abstract][Full Text] [Related]
5. RNA In Situ Hybridization for Epstein-Barr Virus and Cytomegalovirus: Comparison With In Situ Hybridization and Immunohistochemistry.
Roe CJ; Siddiqui MT; Lawson D; Cohen C
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):155-159. PubMed ID: 28800011
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the association of Epstein-Barr Virus in breast cancer in Indian patients using in-situ hybridization technique.
Pai T; Gupta S; Gurav M; Nag S; Shet T; Patil A; Desai S
Breast J; 2018 Jan; 24(1):16-22. PubMed ID: 28557251
[TBL] [Abstract][Full Text] [Related]
7. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma.
Tsai ST; Jin YT; Mann RB; Ambinder RF
Cancer; 1998 Apr; 82(8):1449-53. PubMed ID: 9554519
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
Simon J; Schroeder L; Ingarfield K; Diehl S; Werner J; Brenner N; Liu Z; Pawlita M; Pring M; Butt J; Ness A; Waterboer T
Int J Cancer; 2020 Jul; 147(2):461-471. PubMed ID: 32279316
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel.
Bar-Sela G; Kuten A; Minkov I; Gov-Ari E; Ben-Izhak O
J Clin Pathol; 2004 Mar; 57(3):290-3. PubMed ID: 14990602
[TBL] [Abstract][Full Text] [Related]
11. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody.
Brousset P; Butet V; Chittal S; Selves J; Delsol G
Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma.
Zeng Z; Fan S; Zhang X; Li S; Zhou M; Xiong W; Tan M; Zhang W; Li G
Clin Transl Oncol; 2016 Feb; 18(2):206-11. PubMed ID: 26260913
[TBL] [Abstract][Full Text] [Related]
13. [Primary adenoid cystic carcinoma of the nasopharynx and its relation to Epstein-Barr virus infection].
He JH; Zong YS; Zhang M; Zhong BL; Liang YJ; Liang XM
Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):234-7. PubMed ID: 12882689
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Significance of IGF-1R and Relationship with Epstein-Barr Virus Markers: LMP1 and EBERs in Tunisian Patients with Nasopharyngeal Carcinoma.
Baizig NM; Wided BA; Amine OE; Gritli S; ElMay M
Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):1011-1019. PubMed ID: 32468823
[TBL] [Abstract][Full Text] [Related]
15. Association of Epstein-Barr virus and nasopharyngeal carcinoma in Caucasian patients.
Plaza G; Manzanal AI; Fogué L; Santón A; Martínez-Montero JC; Bellas C
Ann Otol Rhinol Laryngol; 2002 Mar; 111(3 Pt 1):210-6. PubMed ID: 11913680
[TBL] [Abstract][Full Text] [Related]
16. High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.
Hui KF; Chan TF; Yang W; Shen JJ; Lam KP; Kwok H; Sham PC; Tsao SW; Kwong DL; Lung ML; Chiang AKS
Int J Cancer; 2019 Jun; 144(12):3031-3042. PubMed ID: 30536939
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
18. Roles of DNA cytometry and detection of EBERs in predicting a diagnosis of nasopharyngeal carcinoma.
Maohuai C; Chang AR; Shikyuen L
Anal Quant Cytol Histol; 2001 Jun; 23(3):207-12. PubMed ID: 11444190
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative and localized detection of Epstein-Barr virus infectious status in nasopharyngeal carcinoma tissue].
Jiang WH; Zhao SP; Yin ZH; Li F; Chen ZH; Xiao JY
Ai Zheng; 2005 Jul; 24(7):796-800. PubMed ID: 16004803
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
